Total Liabilities: The total value of all possible claims against the corporation.
Anavex Life Sciences Corp. (AVXL) had Total Liabilities of $11.47M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-13.24M |
|
-- |
|
-- |
|
$14.46M |
|
$-14.46M |
|
$1.22M |
|
$-13.24M |
|
$-13.24M |
|
$-13.24M |
|
$-13.24M |
|
$-13.24M |
|
$-13.24M |
|
$-14.46M |
|
$-14.46M |
|
85.38M |
|
85.38M |
|
$-0.16 |
|
$-0.16 |
|
Balance Sheet Financials | |
$102.43M |
|
-- |
|
-- |
|
$102.43M |
|
$11.47M |
|
-- |
|
-- |
|
Total Liabilities |
$11.47M |
$90.96M |
|
$90.96M |
|
$90.96M |
|
85.41M |
|
Cash Flow Statement Financials | |
$-30.44M |
|
-- |
|
$-0.58M |
|
$132.19M |
|
$101.16M |
|
$-31.02M |
|
$7.83M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
8.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.56% |
|
-14.56% |
|
-12.93% |
|
-14.56% |
|
$1.06 |
|
$-0.36 |
|
$-0.36 |